Cargando…

Low‐Intensity Vibration Protects the Weight‐Bearing Skeleton and Suppresses Fracture Incidence in Boys With Duchenne Muscular Dystrophy: A Prospective, Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial

The ability of low‐intensity vibration (LIV) to combat skeletal decline in Duchenne Muscular Dystrophy (DMD) was evaluated in a randomized controlled trial. Twenty DMD boys were enrolled, all ambulant and treated with glucocorticoids (mean age 7.6, height‐adjusted Z‐scores [HAZ] of hip bone mineral...

Descripción completa

Detalles Bibliográficos
Autores principales: Bianchi, Maria Luisa, Vai, Silvia, Baranello, Giovanni, Broggi, Francesca, Judex, Stefan, Hangartner, Thomas, Rubin, Clinton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664527/
https://www.ncbi.nlm.nih.gov/pubmed/36398114
http://dx.doi.org/10.1002/jbm4.10685
_version_ 1784831120400973824
author Bianchi, Maria Luisa
Vai, Silvia
Baranello, Giovanni
Broggi, Francesca
Judex, Stefan
Hangartner, Thomas
Rubin, Clinton
author_facet Bianchi, Maria Luisa
Vai, Silvia
Baranello, Giovanni
Broggi, Francesca
Judex, Stefan
Hangartner, Thomas
Rubin, Clinton
author_sort Bianchi, Maria Luisa
collection PubMed
description The ability of low‐intensity vibration (LIV) to combat skeletal decline in Duchenne Muscular Dystrophy (DMD) was evaluated in a randomized controlled trial. Twenty DMD boys were enrolled, all ambulant and treated with glucocorticoids (mean age 7.6, height‐adjusted Z‐scores [HAZ] of hip bone mineral density [BMD] −2.3). Ten DMD boys were assigned to stand for 10 min/d on an active LIV platform (0.4 g at 30 Hz), while 10 stood on a placebo device. Baseline and 14‐month bone mineral content (BMC) and BMD of spine, hip, and total body were measured with DXA, and trabecular bone density (TBD) of tibia with quantitative computed tomography (QCT). All children tolerated the LIV intervention well, with daily compliance averaging 78%. At 14 months, TBD in the proximal and distal tibia remained unchanged in placebo subjects (−1.0% and −0.2%), while rising 3.5% and 4.6% in LIV subjects. HAZ for hip BMD and BMC in the placebo group declined 22% and 13%, respectively, contrasting with no change from baseline (0.9% and 1.4%) in the LIV group. Fat mass in the leg increased 32% in the placebo group, contrasting with 21% in LIV subjects. Across the 14‐month study, there were four incident fractures in three placebo patients (30%), with no new fractures identified in LIV subjects. Despite these encouraging results, a major limitation of the study is—despite randomized enrollment—that there was a significant difference in age between the two cohorts, with the LIV group being 2.8y older, and thus at greater severity of disease. In sum, these data suggest that noninvasive LIV can help protect the skeleton of DMD children against the disease progression, the consequences of diminished load bearing, and the complications of chronic steroid use. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
format Online
Article
Text
id pubmed-9664527
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-96645272022-11-16 Low‐Intensity Vibration Protects the Weight‐Bearing Skeleton and Suppresses Fracture Incidence in Boys With Duchenne Muscular Dystrophy: A Prospective, Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial Bianchi, Maria Luisa Vai, Silvia Baranello, Giovanni Broggi, Francesca Judex, Stefan Hangartner, Thomas Rubin, Clinton JBMR Plus Clinical Trial The ability of low‐intensity vibration (LIV) to combat skeletal decline in Duchenne Muscular Dystrophy (DMD) was evaluated in a randomized controlled trial. Twenty DMD boys were enrolled, all ambulant and treated with glucocorticoids (mean age 7.6, height‐adjusted Z‐scores [HAZ] of hip bone mineral density [BMD] −2.3). Ten DMD boys were assigned to stand for 10 min/d on an active LIV platform (0.4 g at 30 Hz), while 10 stood on a placebo device. Baseline and 14‐month bone mineral content (BMC) and BMD of spine, hip, and total body were measured with DXA, and trabecular bone density (TBD) of tibia with quantitative computed tomography (QCT). All children tolerated the LIV intervention well, with daily compliance averaging 78%. At 14 months, TBD in the proximal and distal tibia remained unchanged in placebo subjects (−1.0% and −0.2%), while rising 3.5% and 4.6% in LIV subjects. HAZ for hip BMD and BMC in the placebo group declined 22% and 13%, respectively, contrasting with no change from baseline (0.9% and 1.4%) in the LIV group. Fat mass in the leg increased 32% in the placebo group, contrasting with 21% in LIV subjects. Across the 14‐month study, there were four incident fractures in three placebo patients (30%), with no new fractures identified in LIV subjects. Despite these encouraging results, a major limitation of the study is—despite randomized enrollment—that there was a significant difference in age between the two cohorts, with the LIV group being 2.8y older, and thus at greater severity of disease. In sum, these data suggest that noninvasive LIV can help protect the skeleton of DMD children against the disease progression, the consequences of diminished load bearing, and the complications of chronic steroid use. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research. John Wiley & Sons, Inc. 2022-10-18 /pmc/articles/PMC9664527/ /pubmed/36398114 http://dx.doi.org/10.1002/jbm4.10685 Text en © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Trial
Bianchi, Maria Luisa
Vai, Silvia
Baranello, Giovanni
Broggi, Francesca
Judex, Stefan
Hangartner, Thomas
Rubin, Clinton
Low‐Intensity Vibration Protects the Weight‐Bearing Skeleton and Suppresses Fracture Incidence in Boys With Duchenne Muscular Dystrophy: A Prospective, Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial
title Low‐Intensity Vibration Protects the Weight‐Bearing Skeleton and Suppresses Fracture Incidence in Boys With Duchenne Muscular Dystrophy: A Prospective, Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial
title_full Low‐Intensity Vibration Protects the Weight‐Bearing Skeleton and Suppresses Fracture Incidence in Boys With Duchenne Muscular Dystrophy: A Prospective, Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial
title_fullStr Low‐Intensity Vibration Protects the Weight‐Bearing Skeleton and Suppresses Fracture Incidence in Boys With Duchenne Muscular Dystrophy: A Prospective, Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial
title_full_unstemmed Low‐Intensity Vibration Protects the Weight‐Bearing Skeleton and Suppresses Fracture Incidence in Boys With Duchenne Muscular Dystrophy: A Prospective, Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial
title_short Low‐Intensity Vibration Protects the Weight‐Bearing Skeleton and Suppresses Fracture Incidence in Boys With Duchenne Muscular Dystrophy: A Prospective, Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial
title_sort low‐intensity vibration protects the weight‐bearing skeleton and suppresses fracture incidence in boys with duchenne muscular dystrophy: a prospective, randomized, double‐blind, placebo‐controlled clinical trial
topic Clinical Trial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664527/
https://www.ncbi.nlm.nih.gov/pubmed/36398114
http://dx.doi.org/10.1002/jbm4.10685
work_keys_str_mv AT bianchimarialuisa lowintensityvibrationprotectstheweightbearingskeletonandsuppressesfractureincidenceinboyswithduchennemusculardystrophyaprospectiverandomizeddoubleblindplacebocontrolledclinicaltrial
AT vaisilvia lowintensityvibrationprotectstheweightbearingskeletonandsuppressesfractureincidenceinboyswithduchennemusculardystrophyaprospectiverandomizeddoubleblindplacebocontrolledclinicaltrial
AT baranellogiovanni lowintensityvibrationprotectstheweightbearingskeletonandsuppressesfractureincidenceinboyswithduchennemusculardystrophyaprospectiverandomizeddoubleblindplacebocontrolledclinicaltrial
AT broggifrancesca lowintensityvibrationprotectstheweightbearingskeletonandsuppressesfractureincidenceinboyswithduchennemusculardystrophyaprospectiverandomizeddoubleblindplacebocontrolledclinicaltrial
AT judexstefan lowintensityvibrationprotectstheweightbearingskeletonandsuppressesfractureincidenceinboyswithduchennemusculardystrophyaprospectiverandomizeddoubleblindplacebocontrolledclinicaltrial
AT hangartnerthomas lowintensityvibrationprotectstheweightbearingskeletonandsuppressesfractureincidenceinboyswithduchennemusculardystrophyaprospectiverandomizeddoubleblindplacebocontrolledclinicaltrial
AT rubinclinton lowintensityvibrationprotectstheweightbearingskeletonandsuppressesfractureincidenceinboyswithduchennemusculardystrophyaprospectiverandomizeddoubleblindplacebocontrolledclinicaltrial